Vonderheide, Robert H
Kraynyak, Kimberly A https://orcid.org/0000-0001-9233-8858
Shields, Anthony F
McRee, Autumn J
Johnson, Jennifer M
Sun, Weijing
Chintakuntlawar, Ashish V
Pawlicki, Jan
Sylvester, Albert J
McMullan, Trevor
Samuels, Robert
Kim, Joseph J
Weiner, David
Boyer, Jean D
Morrow, Matthew P
Humeau, Laurent
Skolnik, Jeffrey M
Clinical trials referenced in this document:
Documents that mention this clinical trial
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors
https://doi.org/10.1136/jitc-2021-003019
Documents that mention this clinical trial
SITC strategic vision: prevention, premalignant immunity, host and environmental factors
https://doi.org/10.1136/jitc-2024-010419
Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors
https://doi.org/10.1136/jitc-2021-003019
Shared epitopes create safety and efficacy concerns in several cancer vaccines
https://doi.org/10.1136/jitc-2025-012217
Advances and challenges in cancer immunoprevention and immune interception
https://doi.org/10.1136/jitc-2023-007815